drugset / Trial / NCT04487925
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, randomized, single center, phase 4 controlled trial. The study will compare the efficacy of two different strategies for the management of predicted poor response patients under stimulation for IVF/ICSI: up to three MNC cycles (group 1) versus a single GnRH antagonist CFA (group 2).
Timeline
- Start
- 2022-01-25
- Primary completion
- 2024-09-30
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Corifollitropin alfa | Protein / enzyme biologic | — | — |
| Comparator | Follitropin beta | Protein / enzyme biologic | — | — |